SABRIL

LOE Approaching

vigabatrin

NDAORALFOR SOLUTIONPriority Review
Approved
Aug 2009
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Mechanism of Action

Pharmacologic Class:

Anti-epileptic Agent

Clinical Trials (4)

NCT01281202Phase 2/3Completed

Vigabatrin for the Treatment of Cocaine Dependency

Started Jan 2011
207 enrolled
Cocaine AddictionCocaine Dependence
NCT00730522Phase 2Terminated

Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence

Started Jul 2008
55 enrolled
Methamphetamine Dependence
NCT00611130Phase 2Completed

Vigabatrin for Treatment of Cocaine Dependence

Started Jan 2008
186 enrolled
Cocaine Dependence
NCT00527683Phase 2Completed

Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

Started Apr 2007
100 enrolled
Cocaine Dependence